ArticlePilot and feasibility studies2018

Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment.

Thomas A Shepherd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.